🇺🇸 FDA

Company profile · Sponsor

MBX

MBX Biosciences

MBX · NYSE pharma CARMEL, IN, USA
Pipeline
7
Drugs
0
Patents
0

Quick answer

MBX (MBX) is a pharma company. headquartered in CARMEL, IN, USA. listed on NYSE. NovaPharmaNews links 7 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker MBX
Exchange NYSE
Company type pharma
Headquarters CARMEL, IN, USA
SEC CIK 0001776111

Pipeline (7)

Search pipeline →

  1. 400 µg of MBX 2109 once-weekly by subcutaneous injection

    MBX

    Hypoparathyroidism

    phase 2 small molecule active

    1 trial

  2. MBX 1416 (INN imapextide)

    MBX

    Postbariatric Hypoglycemia

    phase 2 small molecule active

    1 trial

  3. MBX 2109

    MBX

    Hypoparathyroidism

    phase 2 small molecule completed

    1 trial

  4. MBX 1416 (Part A)

    MBX

    Postbariatric Hypoglycemia

    phase 1 small molecule completed

    1 trial

  5. MBX 2109

    MBX

    Renal Impairment

    phase 1 small molecule completed

    1 trial

  6. MBX 2109 (Part A)

    MBX

    Healthy

    phase 1 small molecule completed

    1 trial

  7. MBX 4291

    MBX

    Obesity

    phase 1 small molecule active

    1 trial

Frequently asked questions

What is MBX?

MBX (MBX) is a pharma company. headquartered in CARMEL, IN, USA. listed on NYSE. NovaPharmaNews links 7 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does MBX sponsor?

We track 7 ClinicalTrials.gov-linked programs for MBX, including 400 µg of MBX 2109 once-weekly by subcutaneous injection and 6 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does MBX company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.